50
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Forgetting to Take Medication, Treatment Adherence and Their Relationship with Viral Load Suppression Among People Living with HIV in the Kilimanjaro Region, Tanzania

ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 245-257 | Received 10 Dec 2023, Accepted 17 May 2024, Published online: 17 Jun 2024

References

  • UNAIDS. FACT SHEET 2021 Global HIV Statistics. End AIDS epidemic; 2021:1–3.
  • UNAIDS WU. Country progress report – united Republic of Tanzania. 2020:1–42.
  • IMPACTSURVEY, TANZANIA HEALTH; 2018.
  • MoHCDGEC. Health sector strategic plan 2012-2018; 2021.
  • UNAIDS. Understanding fast-track targets. Accelerating action to end the AIDS epidemic by 2030. Unaids; 2015.
  • The IN, African WHO. HIV/AIDS: FRAMEWORK FOR ACTION IN THE WHO AFRICAN REGION, 2016 - 2020: End HIV / Aids By 2030. 2020:2016–2020.
  • O’Halloran Leach E, Lu H, Caballero J, Thomas JE, Spencer EC, Cook RL. Defining the optimal cut-point of self-reported ART adherence to achieve viral suppression in the era of contemporary HIV therapy: a cross-sectional study. AIDS Res Ther. 2021;18(1):36. doi:10.1186/s12981-021-00358-8
  • Wakibi SN, Ng ZW, Mbugua GG. Factors associated with non-adherence to highly active antiretroviral therapy in Nairobi, Kenya. AIDS Res Ther. 2011;8:1–8.
  • World Health Organization. People Living with HIV Who Have Suppressed Viral Loads. WHO Consol HIV Strateg Inf Guidel; 2020:17–21.
  • Shubber Z, Mills EJ, Nachega JB, et al. Patient-Reported Barriers to Adherence to Antiretroviral Therapy: a Systematic Review and Meta-Analysis. PLoS Med. 2016;13(11):1–14. doi:10.1371/journal.pmed.1002183
  • Koole O, Denison JA, Menten J, et al. Reasons for missing antiretroviral therapy: results from a multi-country study in Tanzania, Uganda, and Zambia. PLoS One. 2016;11(1):2–7. doi:10.1371/journal.pone.0147309
  • Mugusi SF, Mopei N, Minzi O. Adherence to combination antiretroviral therapy among orphaned children in Dar es Salaam, Tanzania. South Afr J HIV Med. 2019;20:1–8.
  • Sangeda RZ, Mosha F, Aboud S. Predictors of non adherence to antiretroviral therapy at an urban HIV care and treatment center in Tanzania. Drug Healthc Patient Saf. 2018;10:79–88. doi:10.2147/DHPS.S143178
  • Nyogea D, Mtenga S, Henning L, et al. Determinants of antiretroviral adherence among HIV positive children and teenagers in rural Tanzania: a mixed methods study. BMC Infect Dis. 2015;15(1):1–13. doi:10.1186/s12879-015-0753-y
  • Mussa FM, Massawe HP, Bhalloo H, Moledina S, Assenga E. Magnitude and associated factors of antiretroviral therapy adherence among children attending HIV care and treatment clinics in Dar es Salaam, Tanzania. PLoS One. 2022;17(9 September):e0275420. doi:10.1371/journal.pone.0275420
  • Lecher SL, Fonjungo P, Ellenberger D, Toure CA, Alemnji G, Bowen N. HIV viral load monitoring among patients receiving antiretroviral therapy — eight Sub-Saharan Africa Countries, 2013 – 2018. MMWR Morb Mortal Wkly Rep. 2021;70(21):775–778. doi:10.15585/mmwr.mm7021a2
  • Colvin CJ, Konopka S, Chalker JC, et al. A systematic review of health system barriers and enablers for Antiretroviral Therapy (ART) for HIV-infected pregnant and postpartum women. PLoS One. 2014;9(10):e108150. doi:10.1371/journal.pone.0108150
  • Ngandu NK, Lombard CJ, Mbira TE, et al. HIV viral load non- - suppression and associated factors among pregnant and postpartum women in rural northeastern South Africa: a cross- - sectional survey. BMJ open. 2022;12:1–12. doi:10.1136/bmjopen-2021-058347
  • Jobanputra K, Parker LA, Azih C, et al. Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland. PLoS One. 2015;10(2):1–12. doi:10.1371/journal.pone.0116144
  • Plymoth M, Sanders EJ, Van Der Elst EM, et al. Socio-economic condition and lack of virological suppression among adults and adolescents receiving antiretroviral therapy in Ethiopia. PLoS One. 2020;15(12):1–18. doi:10.1371/journal.pone.0244066
  • de BMS, Pima FM, Ngowi KM, et al. Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized c. Trials. 2019;20:1–10.
  • Sumari-de Boer IM, Ngowi KM, Sonda TB, et al. Effect of digital adherence tools on adherence to antiretroviral treatment among adults living with HIV in Kilimanjaro, Tanzania: a randomized controlled trial. J Acquir Immune Defic Syndr. 2021;87(5):1136–1144. doi:10.1097/QAI.0000000000002695
  • Alharbi NA, Alkhawaji YA. Use and effectiveness of digital Adherence tools. Saudi J Med Pharm Sci. 2023;4929:155–162. doi:10.36348/sjmps.2023.v09i03.003
  • Baker S, Waterfield J, Bartlam B. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893–1907. doi:10.1007/s11135-017-0574-8
  • Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17(1):1–13. doi:10.1186/s12913-017-2031-8
  • Dyrehave C, Rasmussen DN, Hønge BL, et al. Nonadherence is associated with Lack of HIV-related knowledge. J Int Assoc Provid AIDS Care. 2016;15(4):350–358. doi:10.1177/2325957415599211
  • Province L, Africa S. Determinants of poor adherence to antiretroviral treatment using a combined effect of age and education among human immunodeficiency virus infected young adults attending care at Letaba Hospital HIV Clinic, Limpopo Province. South Africa. 2019;8688:1–14. doi:10.11604/pamj.2019.32.37.17722
  • Kiweewa F, Esber A, Musingye E, et al. HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study. PLoS One. 2019;14(2):1–16. doi:10.1371/journal.pone.0211344
  • O’Connor JL, Gardner EM, Esser S, et al. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy. HIV Med. 2016;17(2):124–132. doi:10.1111/hiv.12284
  • Tanyi WN, Gachuno O, Odero T, Farquhar C, Kimosop D, Mayi A. Factors affecting adherence to antiretroviral therapy among children and adolescents living with HIV in the mbita sub-county hospital, homa bay-Kenya. Afr Health Sci. 2021;21(1):18–24. doi:10.4314/ahs.v21i.4S
  • Ugwu R, Eneh A. Factors influencing adherence to paediatric antiretroviral therapy in Portharcourt, South- South Nigeria. Pan Afr Med J. 2013;16:1–9. doi:10.11604/pamj.2013.16.30.1877
  • Shah GH, Maluantesa L, Etheredge GD, et al. HIV viral suppression among people living with HIV on Antiretroviral Therapy in Haut-Katanga and Kinshasa Provinces of Democratic Republic of Congo; 2022.
  • Mayanja BN, Kabunga E, Masiira B, Lubega R, Kaleebu P, Seeley J. Personal barriers to antiretroviral therapy adherence: case studies from a rural Uganda prospective clinical cohort. Afr Health Sci. 2013;13(2):311–319. doi:10.4314/ahs.v13i2.16
  • Cruz MLS, Cardoso CAA, Darmont MQ, et al. Viral suppression and adherence among HIV-infected children and adolescents on antiretroviral therapy: results of a multicenter study. J Pediatr. 2014;90(6):563–571. doi:10.1016/j.jped.2014.04.007
  • Ngowi KM, Maro E, Aarnoutse RE, et al. Feasibility of SMS to remind pregnant and breastfeeding women living with HIV to take antiretroviral treatment in Kilimanjaro region, Tanzania: a pilot study. East African Heal Res J. 2020;4(2):140–148. doi:10.24248/eahrj.v4i2.637
  • Chen Y, Chen K, Kalichman SC. Barriers to HIV Medication Adherence as a Function of Regimen Simplification. Ann Behav Med. 2017;51(1):67–78. doi:10.1007/s12160-016-9827-3
  • Gokarn A, Narkhede MG, Pardeshi GS. Adherence to Antiretroviral Therapy. Japi. 2019;60:17.
  • Buregyeya E, Naigino R, Mukose A, et al. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study. BMC Pregnancy Childbirth. 2017;17:1–9. doi:10.1186/s12884-017-1276-x
  • Maina EK, Mureithi H, Adan AA, Muriuki J, Lwembe RM, Bukusi EA. International Journal of Infectious Diseases Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya. Int J Infect Dis. 2020;97:151–158. doi:10.1016/j.ijid.2020.05.097
  • Lyimo RA, De Bruin M, Van Den Boogaard J, Hospers HJ, Van Der Ven A, Mushi D. Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective. BMC Public Health. 2012;12(1). doi:10.1186/1471-2458-12-716
  • Care P, Ejigu M, Desalegn Z, Mosisa G. Adherence to combined antiretroviral therapy and associated factors among people living with HIV attending nekemte specialized hospital, Oromia, Ethiopia: a Cross-Sectional Study. HIV/AIDS-Res Palliative Care. 2020;97–106.
  • Bitwale NZ, Mnzava DP, Kimaro FD, Jacob T, Mpondo BCT, Jumanne S. Prevalence and factors associated with virological treatment failure among children and adolescents on antiretroviral therapy attending HIV / AIDS care and treatment clinics in Dodoma Municipality, Central Tanzania. J Pediatr Infect Dis Soc. 2021;10(2):131–140. doi:10.1093/jpids/piaa030